Description: Explore an FDA-approved oral treatment for adults with active lupus nephritis (LN). Official site for HCPs. See Prescribing Information.
mmf (58) ln (24) first line (24) proteinuria (9) standard of care (8) corticosteroids (8) voclosporin (6) oral medication for lupus nephritis (4) treatment of lupus nephritis (4) renal response (4)
You are using an outdated browser. Please upgrade your browser to improve your experience and security.
INDICATION: LUPKYNIS is indicated in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis (LN) . Limitations of Use : Safety and efficacy of LUPKYNIS have not been established in combination with cyclophosphamide. Use of LUPKYNIS is not recommended in this situation.
Expert Exchange Get Connected Get Connected Resources Expert Exchange Get Connected How Lupkynis Works Efficacy Safety Dosing Patient Profiles Starting Patients Resources Expert Exchange Get Connected Important Safety Information Prescribing Information AURINIA ALLIANCE ® Site Patient Site Improve Clinical Outcomes in Lupus Nephritis With...